Genomics and Proteomic Approach in the Treatment of Various Human Diseases: Applications of Genomics and Proteomics

Genomics and Proteomic Approach in the Treatment of Various Human Diseases: Applications of Genomics and Proteomics

Urmila Jarouliya, Raj K. Keservani
Copyright: © 2017 |Pages: 27
ISBN13: 9781522507543|ISBN10: 152250754X|EISBN13: 9781522507550
DOI: 10.4018/978-1-5225-0754-3.ch004
Cite Chapter Cite Chapter

MLA

Jarouliya, Urmila, and Raj K. Keservani. "Genomics and Proteomic Approach in the Treatment of Various Human Diseases: Applications of Genomics and Proteomics." Recent Advances in Drug Delivery Technology, edited by Raj K. Keservani, et al., IGI Global, 2017, pp. 97-123. https://doi.org/10.4018/978-1-5225-0754-3.ch004

APA

Jarouliya, U. & Keservani, R. K. (2017). Genomics and Proteomic Approach in the Treatment of Various Human Diseases: Applications of Genomics and Proteomics. In R. Keservani, A. Sharma, & R. Kesharwani (Eds.), Recent Advances in Drug Delivery Technology (pp. 97-123). IGI Global. https://doi.org/10.4018/978-1-5225-0754-3.ch004

Chicago

Jarouliya, Urmila, and Raj K. Keservani. "Genomics and Proteomic Approach in the Treatment of Various Human Diseases: Applications of Genomics and Proteomics." In Recent Advances in Drug Delivery Technology, edited by Raj K. Keservani, Anil K. Sharma, and Rajesh Kumar Kesharwani, 97-123. Hershey, PA: IGI Global, 2017. https://doi.org/10.4018/978-1-5225-0754-3.ch004

Export Reference

Mendeley
Favorite

Abstract

World wise genomic analysis is beginning to move from the laboratories of basic investigators to large-scale clinical trials. The potential of this technology is to improve diagnosis and tailored treatment of various human diseases. In addition, new data from the emerging proteomics platforms add another layer of molecular information to the study of human disease, as scientists attempt to catalogue a complete list of the proteins encoded by the genome and to establish a ‘bio-signature' profile of human health and disease. In the medical sciences identification of human genome sequence is a significant milestone for all the genes and their regulatory regions which provides the required framework for the genetic blueprint of humankind and that will make possible to recognize the molecular premise of disease. It is accepted that, together, these technologies genomic and proteomic will make easier to study all aspects of genes, gene products and signaling pathways so that the objective of personalised molecular medicine can be achieved.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.